Trials / Terminated
TerminatedNCT03918603
Decrease of Lesions Induced by Mechanical Ventilation During ARDS
Reduction of Mechanical Ventilation-induced Lesions During ARDS With Multimodal Ultra-protective Ventilation in Combination With ECMO
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Modification of mechanically ventilated lesions by an ultra-protective multimodal strategy compared to a protective strategy in patients with veno-venous ECMO for severe ARDS.
Detailed description
the hypothesis is that ECMO, in addition to improving gas exchange, should limit the deleterious effects of mechanical ventilation (mechanical ventilation-induced lesions, VILI) by drastically reducing minute ventilation (volume reduction). current, Vt, reduction of respiratory rate, reduction of mechanical power, reduction of motor pressure or driving pressure), adapting the level of PEEP from the data collected by monitoring oesophageal pressure and systematically performing positioning sessions in the prone position. This ultra-protective strategy could thus promote the restoration of the integrity of the alveolo-capillary membrane and thus facilitate the healing of patients. In order to verify this concept and, if necessary, to propose a study whose objectives would be more clinical (mortality, ventilator-free days), we propose to carry out a study aimed at showing that this ultra-protective multimodal strategy reduces the lesions induced by mechanical ventilation compared to usual protective ventilatory management during the ECMO as proposed in the EOLIA study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ventral décubitus | Patient will have one session at least more than 12 hours between inclusion and H48 of ventral décubitus |
Timeline
- Start date
- 2019-07-03
- Primary completion
- 2021-04-23
- Completion
- 2021-06-23
- First posted
- 2019-04-17
- Last updated
- 2023-07-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03918603. Inclusion in this directory is not an endorsement.